Company Name: |
BOC Sciences
|
Tel: |
16314854226 |
Email: |
info@bocsci.com |
Products Intro: |
Product Name:N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide CAS:1900865-84-0 Package:$1231/100mg
|
|
| N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide Basic information |
Product Name: | N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide | Synonyms: | Dabigatran etexilate-001;Dabigatran Impurity 72;Dabigatran Impurity 8/N-(4-cyanophenyl)-2-[(4-cyanophenyl)amino]-acetamide;Acetamide, N-(4-cyanophenyl)-2-[(4-cyanophenyl)amino]-;Pregabalin Impurity 122;Dabigatran Impurity 82;N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide? (Dabigatran Impurity);Dabigatran Etexilate Impurity 109 | CAS: | 1900865-84-0 | MF: | C16H12N4O | MW: | 276.29 | EINECS: | | Product Categories: | | Mol File: | 1900865-84-0.mol | ![N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide Structure](CAS/20180527/GIF/1900865-84-0.gif) |
| N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide Chemical Properties |
Boiling point | 616.8±50.0 °C(Predicted) | density | 1.28±0.1 g/cm3(Predicted) | pka | 12.98±0.70(Predicted) |
| N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide Usage And Synthesis |
| N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide Preparation Products And Raw materials |
|
Tag:N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide(1900865-84-0)
Related Product Information
|
methyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
Dabigatran Impurity 8
4-methoxy-N-methyl-3-nitrobenzamide
Dabigatran Etexilate iMpurity
Dabigatran etexilate Impurity R
Dabigatran iMpurity J
Dabigatran Etexilate iMpurity I
Tacrolimus Ring-opening Impurity
Dabigatran Impurity p
Dabigatran Etexilate iMpurity H
Dabigatran iMpurity L
Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate (Dabigatran IMpurity)
Dabigatran Impurity 9
Dabigatran Etexilate iMpurity G
(E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity
15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,3-[(1E)-2-[(1R,3R,4R)-3,4-dihydroxycyclohexyl]-1-methylethenyl]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-,(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-
19-Epi FK-506
|